Where Success Begins

Science-led integrated drug discovery: medicinal and synthetic chemistry, computational chemistry, in vitro biosciences, DMPK, compound management and diversity and fragment libraries.

Read more

About Us

BioAscent is a leading provider of integrated drug discovery services

Founded in 2013, BioAscent is a leading provider of integrated drug discovery services based at the former Organon / MSD R&D site in Newhouse, Scotland, UK. Our drug discovery services include de novo assay development, target analysis and bespoke screening strategies, compound screening (including HTS), medicinal and synthetic chemistry, computational chemistry and compound management, all with access to in-house diversity and fragment libraries.

Read more

News

BioAscent's leading expertise in GPCR drug discovery drives customer success

26 November 2024


We never set out to become a specialist GPCR drug discovery company, nor do we see ourselves as one today. Our identity...

Read more

BioAscent awarded prestigious Knowledge Transfer Partnership with Centre for Targeted Protein Degradation at the University of Dundee

04 November 2024


New collaboration to develop innovative chemistry for more efficient protein degrader molecules.BioAscent is proud to an...

Read more

BioAscent welcomes back Nikita Shvedov

16 October 2024


This summer Nikita Shvedov returned to BioAscent to take up a permanent position in the Biosciences team as an Associate...

Read more

Meet the team: Mhairi Matheson

07 October 2024


Mhairi is an experienced medicinal chemist, who has worked at BioAscent for the past six years, and recently transitione...

Read more

Integrated Drug Discovery


Science-led drug discovery

Get in Touch

Let's talk about how we can maximise your drug discovery success.

Contact